The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions. - Azadeh Shoaibi; Hui-Lee Wong; Christian Reich; Keran Moll; Tina Hernandez-Boussard (AMIA, 2020)

Using structured electronic health record (EHR) data to assess claims-based algorithm performance in the Food and Drug Administration (FDA)'s Biologics Effectiveness and Safety (BEST) Initiative network. - Keran Moll; Cindy Ke Zhou; Lisa Kowarski; Shayan Hobbi; Katie Fingar; Patricia Lloyd; Patrick Saunders-Hastings; Joyce Obidi; Steven A. Anderson; Nader Alawar; Veronica Hernandez-Medina; Timothy Burrell; et al. (AMIA, 2022)